JP2004519493A5 - - Google Patents

Download PDF

Info

Publication number
JP2004519493A5
JP2004519493A5 JP2002572770A JP2002572770A JP2004519493A5 JP 2004519493 A5 JP2004519493 A5 JP 2004519493A5 JP 2002572770 A JP2002572770 A JP 2002572770A JP 2002572770 A JP2002572770 A JP 2002572770A JP 2004519493 A5 JP2004519493 A5 JP 2004519493A5
Authority
JP
Japan
Prior art keywords
hydrogen
lower alkyl
combination
bond
combination according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002572770A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004519493A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/002977 external-priority patent/WO2002074042A2/en
Publication of JP2004519493A publication Critical patent/JP2004519493A/ja
Publication of JP2004519493A5 publication Critical patent/JP2004519493A5/ja
Withdrawn legal-status Critical Current

Links

JP2002572770A 2001-03-19 2002-03-18 抗下痢剤およびエポチロンまたはエポチロン誘導体を含む組合せ剤 Withdrawn JP2004519493A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27715301P 2001-03-19 2001-03-19
US27720701P 2001-03-20 2001-03-20
PCT/EP2002/002977 WO2002074042A2 (en) 2001-03-19 2002-03-18 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009196666A Division JP2010006830A (ja) 2001-03-19 2009-08-27 抗下痢剤およびエポチロンまたはエポチロン誘導体を含む組合せ剤

Publications (2)

Publication Number Publication Date
JP2004519493A JP2004519493A (ja) 2004-07-02
JP2004519493A5 true JP2004519493A5 (cg-RX-API-DMAC7.html) 2005-12-22

Family

ID=26958333

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002572770A Withdrawn JP2004519493A (ja) 2001-03-19 2002-03-18 抗下痢剤およびエポチロンまたはエポチロン誘導体を含む組合せ剤
JP2009196666A Pending JP2010006830A (ja) 2001-03-19 2009-08-27 抗下痢剤およびエポチロンまたはエポチロン誘導体を含む組合せ剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009196666A Pending JP2010006830A (ja) 2001-03-19 2009-08-27 抗下痢剤およびエポチロンまたはエポチロン誘導体を含む組合せ剤

Country Status (26)

Country Link
US (1) US7030147B2 (cg-RX-API-DMAC7.html)
EP (1) EP1372650B1 (cg-RX-API-DMAC7.html)
JP (2) JP2004519493A (cg-RX-API-DMAC7.html)
KR (1) KR100863089B1 (cg-RX-API-DMAC7.html)
CN (1) CN100540001C (cg-RX-API-DMAC7.html)
AT (1) ATE414514T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002251067B2 (cg-RX-API-DMAC7.html)
BR (1) BR0208142A (cg-RX-API-DMAC7.html)
CA (1) CA2440111C (cg-RX-API-DMAC7.html)
CY (1) CY1108845T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ302848B6 (cg-RX-API-DMAC7.html)
DE (1) DE60229922D1 (cg-RX-API-DMAC7.html)
DK (1) DK1372650T3 (cg-RX-API-DMAC7.html)
ES (1) ES2318001T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303621A3 (cg-RX-API-DMAC7.html)
IL (1) IL157333A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03008462A (cg-RX-API-DMAC7.html)
NO (1) NO333106B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ541703A (cg-RX-API-DMAC7.html)
PT (1) PT1372650E (cg-RX-API-DMAC7.html)
RU (1) RU2330661C2 (cg-RX-API-DMAC7.html)
SI (1) SI1372650T1 (cg-RX-API-DMAC7.html)
SK (1) SK287334B6 (cg-RX-API-DMAC7.html)
TW (1) TWI331525B (cg-RX-API-DMAC7.html)
WO (1) WO2002074042A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200306318B (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
EP1386922B1 (en) 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
AU2001280120A1 (en) * 2000-08-24 2002-03-04 Chugai Seiyaku Kabushiki Kaisha Cyclic peptide derivative
ATE554756T1 (de) 2001-03-14 2012-05-15 Bristol Myers Squibb Co Kombination aus epothilon-analog und chemotherapeutika zur behandlung von proliferativen erkrankungen
US6727261B2 (en) * 2001-12-27 2004-04-27 Hoffman-La Roche Inc. Pyrido[2,1-A]Isoquinoline derivatives
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
US20040242568A1 (en) * 2003-03-25 2004-12-02 Syrrx, Inc. Dipeptidyl peptidase inhibitors
JP2007511467A (ja) 2003-05-14 2007-05-10 タケダ サン ディエゴ インコーポレイテッド ジペプチジルペプチダーゼインヒビター
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
MXPA06001601A (es) * 2003-08-13 2006-08-25 Takeda Pharmaceutical Derivados de 4-pirimidona y su uso como inhibidores de dipeptidilpeptidasa.
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US20050065144A1 (en) * 2003-09-08 2005-03-24 Syrrx, Inc. Dipeptidyl peptidase inhibitors
WO2005026148A1 (en) * 2003-09-08 2005-03-24 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
CN102079743B (zh) * 2004-03-15 2020-08-25 武田药品工业株式会社 二肽基肽酶抑制剂
RU2253440C1 (ru) * 2004-03-31 2005-06-10 Открытое Акционерное Общество "Фаберлик" Средство для устранения нарушений нейрогенной и эндокринной регуляции системы капиллярного кровотока
US7687638B2 (en) * 2004-06-04 2010-03-30 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US20060121511A1 (en) 2004-11-30 2006-06-08 Hyerim Lee Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
JP2008524331A (ja) 2004-12-21 2008-07-10 武田薬品工業株式会社 ジペプチジルペプチダーゼ阻害剤
EP2634252B1 (en) 2005-02-11 2018-12-19 University of Southern California Method of expressing proteins with disulfide bridges
GEP20135791B (en) * 2005-09-14 2013-03-25 Takeda Pharmaceutical Use of dipeptidyl peptidase inhibitors
NZ566799A (en) * 2005-09-14 2011-04-29 Takeda Pharmaceutical Dipeptidyl peptidase inhibitors for treating diabetes
TW200745080A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
TW200745079A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
WO2007035629A2 (en) 2005-09-16 2007-03-29 Takeda Pharmaceutical Company Limited Process for the preparation of pyrimidinedione derivatives
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
BRPI0820338A2 (pt) * 2007-11-09 2017-05-02 Novartis Ag corticosteroides para tratar a diarreia induzida por epotilona ou derivado da epotilona
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity
CA2927832C (en) 2010-05-18 2021-03-23 Cerulean Pharma Inc. Cyclodextrin-containing polymer-therapeutic agent conjugates and their use
KR101478925B1 (ko) * 2013-12-31 2015-01-08 아주대학교산학협력단 프로테아좀 저해제와 로페라마이드를 유효성분으로 함유하는 암질환 예방 또는 치료용 약학조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301831D0 (sv) * 1993-05-28 1993-05-28 Analytecon S A Pharmaceutical compositions
US5919816A (en) * 1994-11-14 1999-07-06 Bionumerik Pharmaceuticals, Inc. Formulations and methods of reducing toxicity of antineoplastic agents
PL189698B1 (pl) * 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
US5969145A (en) * 1996-08-30 1999-10-19 Novartis Ag Process for the production of epothilones and intermediate products within the process
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
US6103487A (en) * 1997-08-27 2000-08-15 Merck & Co., Inc. Method of treating cancer
US6127390A (en) * 1997-10-02 2000-10-03 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
US6040321A (en) * 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
KR20080016756A (ko) * 1998-02-05 2008-02-21 노파르티스 아게 유기화합물 함유 조성물
FR2775187B1 (fr) * 1998-02-25 2003-02-21 Novartis Ag Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
US6302838B1 (en) * 1998-02-25 2001-10-16 Novartis Ag Cancer treatment with epothilones
BR9916833A (pt) * 1998-12-22 2001-09-25 Novartis Ag Derivados de epotilona e seu uso como agentes antitumor
US20020045609A1 (en) 2000-05-26 2002-04-18 Gary Ashley Epothilone derivatives and methods for making and using the same
AU2003235761A1 (en) * 2002-01-14 2003-07-24 Novartis Ag Combinations comprising epothilones and anti-metabolites

Similar Documents

Publication Publication Date Title
CA2440111A1 (en) Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
JP2005512995A5 (cg-RX-API-DMAC7.html)
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
AR028504A2 (es) Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial
JP2004504406A5 (cg-RX-API-DMAC7.html)
HRP20161444T1 (hr) Farmaceutski pripravci koji sadrže lokalni anestetik kao što je bupivakain za lokalnu primjenu u usta ili grlo
US8703823B2 (en) Methods for treatment of migraine and symptoms thereof
JP2009525343A5 (cg-RX-API-DMAC7.html)
AR048431A1 (es) Formulaciones galenicas de compuestos organicos
RU2004135563A (ru) Лекарственное средство для лечения повышенной активности мочевого пузыря
WO2004045593A3 (en) Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
HK1042303A1 (zh) 新的化合物
KR101450345B1 (ko) 특히 토가바이러스에 의해 유발된 염증성 증상의 예방 또는조기 치료를 위한 항히스타민제의 새로운 용도
SE0002476D0 (sv) New compounds
ES2267841T3 (es) Uso de una derivado de alfa-halogeno-acriloil distamicina para la preparacion de un medicamento para el tratamiento del cancer.
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
ES2459877T3 (es) Combinación de nilotinib y clorambucil para el tratamiento de leucemia linfocítica crónica
JP2005513167A5 (cg-RX-API-DMAC7.html)
RU2005135649A (ru) Комбинации пароксетина и 4-(s)-(4-ацетилпиперазин-1-ил)-2-(r)-(4-фтор-2-метилфенил)пиперидин-1-карбоновой кислоты [1-(r)-(3, 5-бис-трифторметилфенил)этил]метиламида для лечения депрессии и/или тревоги
JP2006508118A5 (cg-RX-API-DMAC7.html)
AR022338A1 (es) Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
JP2021511352A5 (cg-RX-API-DMAC7.html)
RU2005132175A (ru) Комбинированное лечение опухолей, включающее неморубицин и лучевую терапию
CO5271647A1 (es) Metodo para prevenir la diarrea
EP1553938B1 (en) Use of epothilone derivatives for the treatment of hyperparathyroidism